2025
Clostridium difficile Induced Coagulopathy: Implications for Microsurgery in the Setting of Limb Salvage
Rohrich R, Li K, Azimi R, Junn A, Ferdousian S, Lin R, Lee W, Currin M, Youn R, Attinger C, Akbari C, Evans K. Clostridium difficile Induced Coagulopathy: Implications for Microsurgery in the Setting of Limb Salvage. Journal Of Plastic Reconstructive & Aesthetic Surgery 2025 DOI: 10.1016/j.bjps.2025.06.010.Peer-Reviewed Original ResearchClostridium difficile infectionCDI groupFlap takebacksNon-CDI groupImpact of Clostridium difficile infectionPartial flap necrosisLower extremitiesRetrospective cohort studyC. diff infectionFlap complicationsMicrosurgical outcomesFlap necrosisThrombotic complicationsDifficile infectionPedicle thrombosisMicrovascular thrombosisFollow-upClinical managementMultivariate regression modelCohort studyIncreased riskC. difficilePlastic surgeonsPatientsLimb salvageMultifaceted challenges of deep venous thrombosis in the setting tetraplegia and ulcerative colitis: case report
Mapelli P, Wright M, Hrdlicka H, Rosenblum D. Multifaceted challenges of deep venous thrombosis in the setting tetraplegia and ulcerative colitis: case report. Spinal Cord Series And Cases 2025, 11: 8. PMID: 40169539, PMCID: PMC11961597, DOI: 10.1038/s41394-025-00703-3.Peer-Reviewed Original ResearchConceptsDeep venous thrombosisClostridium difficile infectionSpinal cord injuryUlcerative colitisUC exacerbationVenous thrombosisDifficile infectionCase reportIncreased risk of deep venous thrombosisPotential risk of progressionCase presentationA 53-year-old maleTreatment of deep venous thrombosisRisk of deep venous thrombosisBowel programKnee deep venous thrombosisDeep venous thrombosis prophylaxisRisk of progressionBilateral lower extremitiesRisk of thrombosisInflammatory bowel diseaseRisk of diarrheaBleeding complicationsDiscontinuing anticoagulationBleeding riskIVC filters
2024
Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration
Toenges R, Lang F, Ghaffar R, Lindner S, Schlipfenbacher V, Riemann J, Ajib S, Kouidri K, Cremer A, Weber B, Nguyen N, Knoch A, Vehreschild J, Serve H, Bug G. Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration. Annals Of Hematology 2024, 103: 4687-4699. PMID: 39237814, DOI: 10.1007/s00277-024-05986-4.Peer-Reviewed Original ResearchGraft-versus-host diseaseSystemic antibiotic prophylaxisNon-relapse mortalityChronic graft-versus-host diseaseAllogeneic hematopoietic stem cell transplantationHematopoietic stem cell transplantationStem cell transplantationClostridium difficile infectionAntibiotic prophylaxisOverall survivalCumulative incidenceBloodstream infectionsCell transplantationAntibiotic treatmentCumulative incidence of acute GVHD grades II-IVSevere chronic graft-versus-host diseaseRisk of graft-versus-host diseaseAcute GVHD grade II-IVGVHD grade II-IVDuration of antibiotic therapyRisk of infection-related mortalityPre-engraftment periodGrade II-IVMedian Follow-UpInfection-related mortality
2023
Stress Ulcer Prophylaxis in Mechanically Ventilated Patients With Acute Myocardial Infarction
Banna S, Schenck C, Shahu A, Thomas A, Heck C, Tangredi R, Ali T, Miller P. Stress Ulcer Prophylaxis in Mechanically Ventilated Patients With Acute Myocardial Infarction. JACC Advances 2023, 3: 100750. PMID: 38939822, PMCID: PMC11198220, DOI: 10.1016/j.jacadv.2023.100750.Peer-Reviewed Original ResearchInvasive mechanical ventilationProton pump inhibitorsStress ulcer prophylaxisAcute myocardial infarctionUlcer prophylaxisVentilator-associated pneumoniaMyocardial infarctionVentilator daysST-segment elevation myocardial infarctionBackground Proton pump inhibitorsLess ventilator-associated pneumoniaVizient Clinical Data BaseObservation cohort studyProportion of patientsElevation myocardial infarctionMultivariable logistic regressionClostridium difficile infectionLower hospitalization costsClinical data baseCardiogenic shockHospital mortalityCohort studyMultivariate adjustmentHospitalization costsMechanical ventilation
2020
UTILIZATION AND OUTCOMES OF CARDIAC CATHETERIZATION IN PATIENTS ADMITTED WITH NON ST-ELEVATION MYOCARDIAL INFARCTION AND CLOSTRIDIUM DIFFICILE INFECTION
Olagoke O, Quelal K, Akintoye E, Nwaichi C, Iriagbonse R, Golzar Y. UTILIZATION AND OUTCOMES OF CARDIAC CATHETERIZATION IN PATIENTS ADMITTED WITH NON ST-ELEVATION MYOCARDIAL INFARCTION AND CLOSTRIDIUM DIFFICILE INFECTION. Journal Of The American College Of Cardiology 2020, 75: 1519. DOI: 10.1016/s0735-1097(20)32146-x.Peer-Reviewed Original ResearchNon-ST elevation myocardial infarctionST-elevation myocardial infarctionClostridium difficile infection
2019
National Trends in Healthcare-Associated Infections for Five Common Cardiovascular Conditions
Miller PE, Guha A, Khera R, Chouairi F, Ahmad T, Nasir K, Addison D, Desai NR. National Trends in Healthcare-Associated Infections for Five Common Cardiovascular Conditions. The American Journal Of Cardiology 2019, 124: 1140-1148. PMID: 31371062, PMCID: PMC7883647, DOI: 10.1016/j.amjcard.2019.06.029.Peer-Reviewed Original ResearchConceptsLength of stayCommon cardiovascular conditionCentral line-associated bloodstream infectionsCatheter-associated urinary tract infectionsLine-associated bloodstream infectionsUrinary tract infectionVentilator-associated pneumoniaClostridium difficile infectionCardiovascular conditionsTract infectionsBloodstream infectionsDifficile infectionOutcome of HAICoronary artery bypassTotal hospital chargesAcute myocardial infarctionSkilled care facilityHealthcare-Associated InfectionsValue-based careHospital mortalityArtery bypassCardiogenic shockHeart failurePropensity matchingAtrial fibrillation
2018
482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015
Skrobarcek K, Mu Y, Ahern J, Beldavs Z, Brousseau G, Dumyati G, Farley M, Holzbauer S, Kainer M, Meek J, Perlmutter R, Phipps E, Winston L, Guh A. 482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015. Open Forum Infectious Diseases 2018, 5: s179-s179. PMCID: PMC6253049, DOI: 10.1093/ofid/ofy210.491.Peer-Reviewed Original ResearchClostridium difficile infectionEmerging Infections ProgramSocioeconomic status factorsCDC's Emerging Infections ProgramCA-CDI casesCDI risk factorsSES variablesDays of hospitalizationHealthcare-Associated InfectionsLow-income areasStatus factorsLow incomeMultivariable analysisCA-CDICDI surveillanceDifficile infectionRisk factorsIncidence rateInfections ProgramPositive testPrevention strategiesCensus tractsHealth disparitiesSocial determinantsHealth resources492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries
Hatfield K, Baggs J, Winston L, Parker E, Martin B, Meek J, Olson D, Farley M, Revis A, Holzbauer S, Bye M, Wilson L, Perlmutter R, Phipps E, Pierce R, Ocampo V, Kainer M, Smith M, McDonald L, Jernigan J, Guh A. 492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries. Open Forum Infectious Diseases 2018, 5: s182-s182. PMCID: PMC6253260, DOI: 10.1093/ofid/ofy210.501.Peer-Reviewed Original ResearchClostridium difficile infectionEmerging Infections ProgramDifficile infectionInclusion criteriaCommon healthcare-associated infectionsPrevention's Emerging Infections ProgramMultivariable logistic regression modelICD-9-CM codesOlder adultsDifficile stool testMedicaid Services beneficiariesNumber of hospitalizationsHealthcare-Associated InfectionsSkilled nursing facilitiesLong-term riskLogistic regression modelsSame catchment areaExcess morbidityHospitalization statusStool testPoor outcomeTerm outcomesAdjusted oddsCDI casesChronic conditions
2017
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
Shallis RM, Terry CM, Lim SH. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. American Journal Of Hematology 2017, 93: 122-128. PMID: 28842931, DOI: 10.1002/ajh.24896.Peer-Reviewed Original ResearchConceptsAllogeneic stem cell transplantStem cell transplantCell transplantIntestinal microbiotaAllogeneic hematopoietic stem cell transplantAllogeneic stem cell transplantationHematopoietic stem cell transplantIntestinal immune toleranceStem cell transplantationClostridium difficile infectionDiverse intestinal microbiotaHuman intestinal microbiotaHost diseaseDisease relapseImmune toleranceCell transplantationDifficile infectionIntestinal microbial communitySystemic conditionsAppropriate treatmentMicrobial homeostasisTransplantPathologic statesMajor causeEarly detectionProspective cluster controlled crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based disinfectant on surface contamination and health care outcomes
Boyce J, Guercia K, Sullivan L, Havill N, Fekieta R, Kozakiewicz J, Goffman D. Prospective cluster controlled crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based disinfectant on surface contamination and health care outcomes. American Journal Of Infection Control 2017, 45: 1006-1010. PMID: 28431849, DOI: 10.1016/j.ajic.2017.03.010.Peer-Reviewed Original ResearchMeSH KeywordsBacterial InfectionsClostridioides difficileColony Count, MicrobialCross InfectionCross-Over StudiesDisinfectantsGuideline AdherenceHand HygieneHealth PersonnelHumansHydrogen PeroxideMethicillin-Resistant Staphylococcus aureusOutcome Assessment, Health CarePatients' RoomsProspective StudiesQuaternary Ammonium CompoundsVancomycin-Resistant EnterococciCosts and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis
Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, Joyce C, Kroshinsky D, Mostaghimi A. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatology 2017, 153: 141-146. PMID: 27806170, DOI: 10.1001/jamadermatol.2016.3816.Peer-Reviewed Original ResearchLower extremity cellulitisExtremity cellulitisMedical Expenditure Panel SurveyEmergency departmentHospital courseUnnecessary antibioticsHealth care spendingDays of dischargeTreatment of cellulitisDiagnosis of cellulitisHealth care burdenNational health care burdenClostridium difficile infectionCases of anaphylaxisUnnecessary patient morbidityCare spendingCross-sectional studyLarge urban hospitalComplication ratePatient characteristicsHospitalization costsInflammatory dermatosesPatient morbidityDifficile infectionAlternative diagnoses
2016
Epidemiology of Clostridium difficile infection in hospitalized oncology patients
Chang GY, Dembry LM, Banach DB. Epidemiology of Clostridium difficile infection in hospitalized oncology patients. American Journal Of Infection Control 2016, 44: 1421-1423. PMID: 27287733, DOI: 10.1016/j.ajic.2016.04.210.Peer-Reviewed Original ResearchConceptsClostridium difficile infectionBlood transfusionDifficile infectionHistory of CDIΒ-lactam/β-lactamase inhibitorsBroad-spectrum antibiotic useHospitalized oncology patientsRecent blood transfusionCDI historyCDI riskOlder patientsOncology inpatientsΒ-lactamase inhibitorsOncology patientsPrior receiptRisk factorsAntibiotic useMultivariate analysisTransfusionPatientsInfectionEpidemiologyInpatientsMetronidazoleCephalosporinsQuantifying Transmission of Clostridium difficile within and outside Healthcare Settings - Volume 22, Number 4—April 2016 - Emerging Infectious Diseases journal - CDC
Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP. Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings - Volume 22, Number 4—April 2016 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2016, 22: 608-616. PMID: 26982504, PMCID: PMC4806959, DOI: 10.3201/eid2204.150455.Peer-Reviewed Original ResearchConceptsClostridium difficile infectionAsymptomatic carriersLong-term care facility settingLong-term care facility residentsHospital-onset Clostridium difficile infectionCare facility residentsEffect of hospitalCommunity-based transmissionCommunity sourcesAsymptomatic patientsCDI incidenceDifficile infectionFacility residentsPatientsControl interventionsDifficile prevalenceC. difficileClostridium difficileHealthcare settingsNational databaseQuantifying transmissionTransmission routesHospitalDifficileControl measuresBurden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
Hunter J, Mu Y, Dumyati G, Farley M, Winston L, Johnston H, Meek J, Perlmutter R, Holzbauer S, Beldavs Z, Phipps E, Dunn J, Cohen J, Avillan J, Stone N, Gerding D, McDonald L, Lessa F. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes. Open Forum Infectious Diseases 2016, 3: ofv196. PMID: 26798767, PMCID: PMC4719744, DOI: 10.1093/ofid/ofv196.Peer-Reviewed Original ResearchClostridium difficile infectionDifficile infectionPatient outcomesPopulation-based surveillanceAcute care settingAppropriate antibiotic useEstimates of incidenceMedian ageSubstantial morbidityPositive stoolsMedical recordsRisk factorsAdvanced ageAntibiotic useInfection preventionAntibiotic exposureHome residentsNational incidenceCare settingsPositive specimenNational estimatesIncidenceSpecimen collectionAgeStool
2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials
Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine 2015, 33: 6241-6249. PMID: 26450660, PMCID: PMC4702247, DOI: 10.1016/j.vaccine.2015.09.078.Peer-Reviewed Original ResearchConceptsEmerging Infections ProgramHigh-risk groupRisk groupsRisk scoreIndex hospitalizationHospital dischargeDerivation cohortVaccine trialsValidation cohortDifficile infectionCox proportional hazards modelRisk of CDIAcute care hospitalizationIdentification of patientsClostridium difficile infectionHospital discharge dataNumber of hospitalizationsLow-risk groupProportional hazards modelLarge academic centerAdmission diagnosisPrimary outcomeInpatient stayPatient populationPharmacy dataQuantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities
Datta R, Brown S, Nguyen VQ, Cao C, Billimek J, Avery T, Lee BY, Huang SS. Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities. Infection Control And Hospital Epidemiology 2015, 36: 1275-1282. PMID: 26387690, DOI: 10.1017/ice.2015.181.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsCaliforniaCarrier StateClostridiumCross InfectionDrug Resistance, BacterialFemaleHospitalsHumansKlebsiella pneumoniaeLength of StayMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedNursing HomesPatient DischargePatient ReadmissionRetrospective StudiesVancomycin-Resistant EnterococciYoung AdultConceptsMethicillin-resistant Staphylococcus aureusClostridium difficile infectionVancomycin-resistant enterococciNursing homesAntibiotic-resistant pathogensDays of dischargeHealthcare facilitiesLength of stayExtended-spectrum β-lactamaseYear of dischargeMultiple cohort studiesTime-dependent exposureESBL carriersMore readmissionsCDI patientsHospital readmissionDifficile infectionSingle hospitalReadmissionHospitalPatientsKlebsiella pneumoniaeΒ-lactamaseStaphylococcus aureusNoncarriersAssociation Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
Dantes R, Mu Y, Hicks L, Cohen J, Bamberg W, Beldavs Z, Dumyati G, Farley M, Holzbauer S, Meek J, Phipps E, Wilson L, Winston L, McDonald L, Lessa F. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infectious Diseases 2015, 2: ofv113. PMID: 26509182, PMCID: PMC4551478, DOI: 10.1093/ofid/ofv113.Peer-Reviewed Original ResearchClostridium difficile infectionCA-CDI ratesOutpatient antibiotic prescribingAntibiotic useAntibiotic prescribingDifficile infectionCommunity-Associated Clostridium difficile InfectionIMS Health Xponent databaseOutpatient antibiotic prescribing practicesAmoxicillin/clavulanic acidCA-CDI casesSurveillance area residentAntibiotic prescribing ratesAntibiotic prescription ratesAntibiotic prescribing practicesCourse of antibioticsOral antibiotic prescriptionsLaboratory-based surveillance dataOutpatient antibiotic useCDI preventionAntibiotic prescriptionsPrescribing ratesHospital admissionPrescription ratesPrescribing practicesUpdate on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015, 149: 223-237. PMID: 25982290, PMCID: PMC4755303, DOI: 10.1053/j.gastro.2015.05.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsFecal microbiota transplantationClostridium difficile infectionGut microbiotaRecurrent Clostridium difficile infectionInflammatory bowel diseaseIrritable bowel syndromeTreatment of patientsRobust safety dataLong-term safetyBowel diseaseBowel syndromeMetabolic syndromeMicrobiota transplantationDifficile infectionSafety dataTherapeutic efficacyOrgan systemsDisease statesHuman gutSyndromePossible roleDiseaseEfficacyMicrobiotaTreatmentBurden of Clostridium difficile Infection in the United States
Lessa F, Mu Y, Bamberg W, Beldavs Z, Dumyati G, Dunn J, Farley M, Holzbauer S, Meek J, Phipps E, Wilson L, Winston L, Cohen J, Limbago B, Fridkin S, Gerding D, McDonald L. Burden of Clostridium difficile Infection in the United States. New England Journal Of Medicine 2015, 372: 825-834. PMID: 25714160, PMCID: PMC10966662, DOI: 10.1056/nejmoa1408913.Peer-Reviewed Original ResearchConceptsClostridium difficile infectionDifficile infectionFirst recurrenceHealth care-associated infectionsCommunity-associated infectionsC. difficile infectionCare-associated infectionsPersons 65 yearsLaboratory-based surveillanceType 1 strainsNumber of deathsNational incidenceMolecular typingC. difficileInfectionIncidenceDeathUnited StatesRecurrenceGeographic areasSample of casesEstimated numberRegression modelsActive populationHealth
2014
Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
Lessa F, Mu Y, Winston L, Dumyati G, Farley M, Beldavs Z, Kast K, Holzbauer S, Meek J, Cohen J, McDonald L, Fridkin S. Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations. Open Forum Infectious Diseases 2014, 1: ofu048. PMID: 25734120, PMCID: PMC4281776, DOI: 10.1093/ofid/ofu048.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply